MEP16708A - Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors - Google Patents

Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors

Info

Publication number: MEP16708A
Authority: ME; Montenegro
Prior art keywords: beta; preparation; amyloid peptide; same; peptide production
Prior art date: 2003-01-23

Application number

MEP-167/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Pierre Despeyroux

Daniel Frehel

Bruno Schoentjes

Dorsselaer Viviane Van

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-23

Filing date

2004-01-22

Publication date

2010-06-10

2004-01-22 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-06-10 Publication of MEP16708A publication Critical patent/MEP16708A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MEP-167/08A 2003-01-23 2004-01-22 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors MEP16708A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0300703A FR2850380B1 (fr)	2003-01-23	2003-01-23	Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
PCT/FR2004/000140 WO2004067520A1 (fr)	2003-01-23	2004-01-22	Derives d'acylaminothiazole, leur preparation et leur utilisation en tant qu’inhibiteurs de la production du peptide beta-amyloide

Publications (1)

Publication Number	Publication Date
MEP16708A true MEP16708A (en)	2010-06-10

Family

ID=32669150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-167/08A MEP16708A (en)	2003-01-23	2004-01-22	Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors

Country Status (24)

Country	Link
US (2)	US7563903B2 (xx)
EP (1)	EP1590337B1 (xx)
JP (1)	JP2006515888A (xx)
KR (1)	KR101059669B1 (xx)
CN (1)	CN100532370C (xx)
AR (1)	AR042745A1 (xx)
AT (1)	ATE404545T1 (xx)
AU (1)	AU2004207658B2 (xx)
BR (1)	BRPI0406893A (xx)
CA (1)	CA2511610A1 (xx)
DE (1)	DE602004015726D1 (xx)
FR (1)	FR2850380B1 (xx)
HR (1)	HRP20050637A2 (xx)
IL (1)	IL169428A (xx)
MA (1)	MA27610A1 (xx)
ME (1)	MEP16708A (xx)
MX (1)	MXPA05007847A (xx)
NO (1)	NO330415B1 (xx)
NZ (1)	NZ541147A (xx)
PL (1)	PL377999A1 (xx)
RS (1)	RS51168B (xx)
RU (1)	RU2360907C2 (xx)
TW (1)	TWI320710B (xx)
WO (1)	WO2004067520A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7759382B2 (en) *	2003-06-05	2010-07-20	Elan Pharmaceuticals, Inc.	Acylated amino acid amidyl pyrazoles and related compounds
MY149143A (en) *	2006-01-18	2013-07-15	Amgen Inc	Thiazole compounds as protien kinase b (pkb) inhibitors
EP2173728A2 (en)	2007-07-17	2010-04-14	Amgen Inc.	Heterocyclic modulators of pkb
CA2693473A1 (en) *	2007-07-17	2009-01-22	Amgen Inc.	Thiadiazole modulators of pkb
US8668863B2 (en)	2008-02-26	2014-03-11	Board Of Regents, The University Of Texas System	Dendritic macroporous hydrogels prepared by crystal templating
EP2371421A1 (en) *	2010-03-04	2011-10-05	Université de Lille 2 Droit et Santé	Ligands of insulin degrading enzyme and their uses
EP2508511A1 (en) *	2011-04-07	2012-10-10	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN103145692B (zh) *	2013-03-12	2014-07-16	盐城工学院	一种4,5-二氢-6H-环戊烷并[b]噻吩-6-酮的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE296797T1 (de) *	1996-11-22	2005-06-15	Elan Pharm Inc	N-(aryl/heteroaryl/alkylacetyl) amino saüre amide,pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
CN1616432A (zh) *	1996-12-23	2005-05-18	伊兰药品公司	化合物、其用途以及含有所述化合物的药物组合物
DE69923681T2 (de) *	1998-06-18	2006-01-12	Bristol-Myers Squibb Co.	Kohlenstoff substituierte aminothiazole als inhibitoren von cyclin-abhängigen kinasen
WO2000024392A1 (fr) *	1998-10-26	2000-05-04	Sumitomo Pharmaceuticals Company, Limited	Inhibiteur de la formation de beta-amyloide
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
AR039059A1 (es) *	2001-08-06	2005-02-09	Sanofi Aventis	Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios

2003
- 2003-01-23 FR FR0300703A patent/FR2850380B1/fr not_active Expired - Fee Related
2004
- 2004-01-22 ME MEP-167/08A patent/MEP16708A/xx unknown
- 2004-01-22 RU RU2005126608/04A patent/RU2360907C2/ru not_active IP Right Cessation
- 2004-01-22 WO PCT/FR2004/000140 patent/WO2004067520A1/fr active IP Right Grant
- 2004-01-22 JP JP2006502115A patent/JP2006515888A/ja not_active Ceased
- 2004-01-22 AT AT04704255T patent/ATE404545T1/de not_active IP Right Cessation
- 2004-01-22 CN CNB2004800027812A patent/CN100532370C/zh not_active Expired - Fee Related
- 2004-01-22 RS YUP-2005/0563A patent/RS51168B/sr unknown
- 2004-01-22 NZ NZ541147A patent/NZ541147A/en not_active IP Right Cessation
- 2004-01-22 BR BR0406893-9A patent/BRPI0406893A/pt not_active IP Right Cessation
- 2004-01-22 KR KR1020057013441A patent/KR101059669B1/ko not_active IP Right Cessation
- 2004-01-22 CA CA002511610A patent/CA2511610A1/en not_active Abandoned
- 2004-01-22 AR ARP040100169A patent/AR042745A1/es unknown
- 2004-01-22 EP EP04704255A patent/EP1590337B1/fr not_active Expired - Lifetime
- 2004-01-22 MX MXPA05007847A patent/MXPA05007847A/es active IP Right Grant
- 2004-01-22 DE DE602004015726T patent/DE602004015726D1/de not_active Expired - Lifetime
- 2004-01-22 PL PL377999A patent/PL377999A1/pl not_active Application Discontinuation
- 2004-01-22 AU AU2004207658A patent/AU2004207658B2/en not_active Ceased
- 2004-01-27 TW TW093101748A patent/TWI320710B/zh not_active IP Right Cessation
2005
- 2005-06-27 IL IL169428A patent/IL169428A/en not_active IP Right Cessation
- 2005-07-12 MA MA28385A patent/MA27610A1/fr unknown
- 2005-07-12 HR HR20050637A patent/HRP20050637A2/hr not_active Application Discontinuation
- 2005-07-21 US US11/186,507 patent/US7563903B2/en not_active Expired - Fee Related
- 2005-07-22 NO NO20053588A patent/NO330415B1/no not_active IP Right Cessation
2009
- 2009-06-22 US US12/488,658 patent/US7879889B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20053588L (no)	2005-09-22
DE602004015726D1 (de)	2008-09-25
MXPA05007847A (es)	2006-05-17
NO20053588D0 (no)	2005-07-22
AR042745A1 (es)	2005-06-29
NZ541147A (en)	2008-06-30
JP2006515888A (ja)	2006-06-08
CA2511610A1 (en)	2004-08-12
ATE404545T1 (de)	2008-08-15
TWI320710B (en)	2010-02-21
US7879889B2 (en)	2011-02-01
RS51168B (sr)	2010-10-31
RU2360907C2 (ru)	2009-07-10
US20090253753A1 (en)	2009-10-08
FR2850380A1 (fr)	2004-07-30
TW200503699A (en)	2005-02-01
KR20050094039A (ko)	2005-09-26
CN100532370C (zh)	2009-08-26
NO330415B1 (no)	2011-04-11
CN1777593A (zh)	2006-05-24
WO2004067520A1 (fr)	2004-08-12
US20060052426A1 (en)	2006-03-09
KR101059669B1 (ko)	2011-08-25
US7563903B2 (en)	2009-07-21
MA27610A1 (fr)	2005-11-01
IL169428A (en)	2010-12-30
AU2004207658B2 (en)	2009-10-29
BRPI0406893A (pt)	2006-01-03
PL377999A1 (pl)	2006-02-20
AU2004207658A1 (en)	2004-08-12
HRP20050637A2 (en)	2005-10-31
EP1590337B1 (fr)	2008-08-13
RS20050563A (xx)	2007-06-04
FR2850380B1 (fr)	2006-07-07
EP1590337A1 (fr)	2005-11-02
RU2005126608A (ru)	2006-04-27

Publication	Publication Date	Title
NO20063821L (no)	2006-08-28	Kinolinderivater for anvendelse som mykobakterielle inhibitorer
ME00159B (me)	2010-10-10	DERIVATI HINOLINA l IZOHINOLINA, POSTUPAK ZA NJIHOVO DOBIJANJE l NJIHOVA PRIMENA KAO SUPRESORA ZAPALJENJA
EA200702670A1 (ru)	2008-04-28	Препарат тиенопиридинового ингибитора агрегации тромбоцитов
NO20050741L (no)	2005-08-15	Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
SG10201809390QA (en)	2018-11-29	Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EA200700192A1 (ru)	2007-06-29	Производные фталазина в качестве ингибиторов parp
RS52534B (en)	2013-04-30	MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
MEP58808A (en)	2011-05-10	Dihydropteridinones, method for the production and use thereof in the form of drugs
EA200700096A1 (ru)	2007-06-29	Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1116885T1 (el)	2017-04-05	Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
MY140841A (en)	2010-01-29	Indozolone derivatives as 11b-hsd1 inhibitors
EA200600621A1 (ru)	2006-10-27	Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE412649T1 (de)	2008-11-15	Substituierte heteroarylbenzofuransäuren
EA200801608A1 (ru)	2008-10-30	Производные бензимидазолонкарбоновой кислоты
EA200600605A1 (ru)	2006-10-27	Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
HRP20050359B1 (hr)	2014-09-26	Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata
NO20085317L (no)	2009-02-05	Imidazoazepinonforbindelser
NO20043016L (no)	2004-07-15	6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
DE502005008057D1 (de)	2009-10-15	Substituierte cyclopenten-verbindungen
DE502006008710D1 (de)	2011-02-24	Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
EA200600100A1 (ru)	2006-08-25	Производные никотинамида, полезные в качестве ингибиторов pde4
MEP16708A (en)	2010-06-10	Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
ATE419242T1 (de)	2009-01-15	Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
RS20060206A (xx)	2008-08-07	Derivati aminopiridina kao inhibitori inducibilne no-sintaze
MXPA05012004A (es)	2006-02-22	Nuevos bioisosteros de actinonina.